Related Experiment Video
Updated: Dec 12, 2025
03:45
Investigating the Pathogenesis of MYH7 Mutation Gly823Glu in Familial Hypertrophic Cardiomyopathy using a Mouse Model
Published on: August 8, 2022
4.0K
Cardiogenetics, 25 years a growing subspecialism
A A M Wilde1, E Nannenberg2, C van der Werf3
1Department of Clinical and Experimental Cardiology, Heart Center, Amsterdam Cardiovascular Sciences, Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands. a.a.wilde@amsterdamumc.nl.
Summary
Cardiogenetics has advanced significantly, identifying genetic mutations for inherited heart conditions. However, interpreting genetic test results, especially with new technologies, presents challenges requiring expert multidisciplinary teams.
Area of Science:
- Cardiology
- Clinical Genetics
- Cardiogenetics
Background:
- The field of cardiogenetics has seen substantial growth over the last 25 years.
- Founder mutations in the Netherlands have offered unique insights into genotype-phenotype correlations for inherited heart conditions.
Purpose of the Study:
- To review progress and challenges in cardiogenetics, focusing on the Netherlands.
- To highlight the importance of genetic testing and interpretation in inherited cardiac diseases.
Main Methods:
- Review of scientific literature and clinical case examples.
- Focus on identified Dutch founder mutations and their impact.
- Discussion of challenges posed by high-throughput sequencing technologies.
Main Results:
- Identification of numerous Dutch founder mutations providing genotype-phenotype insights.
- Successful outcomes from combined cardiological and genetic screening in sudden cardiac death cases.
- Increased complexity in interpreting genetic variants of unknown significance.
Conclusions:
- Multidisciplinary team interpretation of genetic and clinical findings is crucial for patient care.
- Advances in cardiogenetics offer diagnostic and therapeutic potential but require careful interpretation.
- The field faces evolving challenges with new genetic technologies.
Related Concept Videos
01:25Cardiomyopathy I: Introduction and Classification
356
Cardiomyopathy, or CMP, is a group of diseases affecting the myocardial structure, impairing its ability to pump blood effectively. This condition can lead to arrhythmias, heart failure, or sudden cardiac death.Cardiomyopathies are classified into primary and secondary categories:Primary Cardiomyopathy refers to conditions involving only the heart muscle that are often idiopathic (of unknown cause) or genetic. They primarily affect the myocardium without the involvement of other systemic...
356
01:30Cardiomyopathy II: Dilated Cardiomyopathy
293
Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
293
01:29Cardiomyopathy IV: Restrictive Cardiomyopathy
316
Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...
316
01:29Cardiomyopathy III: Hypertrophic Cardiomyopathy
244
Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
244
01:29Cardiomyopathy V: Interprofessional Care
190
Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
190
01:20Blood Studies for Cardiovascular System I: Cardiac Biomarkers
655
Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
655